Abengózar, 2017, Enterocin AS-48 as evidence for the use of bacteriocins as new leishmanicidal agents, Antimicrob. Agents Chemother., 61, 10.1128/AAC.02288-16
Allen, 2003, Clathrin-mediated endocytosis is essential in Trypanosoma brucei, EMBO J., 22, 4991, 10.1093/emboj/cdg481
Alsford, 2012, High-throughput decoding of antitrypanosomal drug efficacy and resistance, Nature, 482, 232, 10.1038/nature10771
Alsford, 2013, Receptor-mediated endocytosis for drug delivery in African trypanosomes: fulfilling Paul Ehrlich's vision of chemotherapy, Trends Parasitol., 29, 207, 10.1016/j.pt.2013.03.004
Ananou, 2008, Optimization of enterocin AS-48 production on a whey-based substrate, Int. Dairy J., 18, 923, 10.1016/j.idairyj.2008.02.001
Bakunova, 2009, Structure-activity study of pentamidine analogues as antiprotozoal agents, J. Med. Chem., 52, 2016, 10.1021/jm801547t
Barrett, 2007, Human African trypanosomiasis: pharmacological re-engagement with a neglected disease, Br. J. Pharmacol., 152, 1155, 10.1038/sj.bjp.0707354
Bart, 2015, Localization of serum resistance-associated protein in Trypanosoma brucei rhodesiense and transgenic Trypanosoma brucei brucei, Cell Microbiol., 17, 1523, 10.1111/cmi.12454
Belmonte-Reche, 2016, Tyrosol and hydroxytyrosol derivatives as antitrypanosomal and antileishmanial agents, Eur. J. Med. Chem., 119, 132, 10.1016/j.ejmech.2016.04.047
Cabello-Donayre, 2016, Trypanosomatid parasites rescue heme from endocytosed hemoglobin through lysosomal HRG transporters, Mol. Microbiol., 101, 895, 10.1111/mmi.13430
Carvalho, 2015, The oral antimalarial drug Tafenoquine shows activity against Trypanosoma brucei, Antimicrob. Agents Chemother., 59, 6151, 10.1128/AAC.00879-15
Castillo-Acosta, 2013, Carbohydrate-binding agents act as potent trypanocidals that elicit modifications in VSG glycosylation and reduced virulence in Trypanosoma brucei, Mol. Microbiol., 90, 665, 10.1111/mmi.12359
Cebrián, 2012, Characterization of functional, safety, and probiotic properties of Enterococcus faecalis UGRA10, a new AS-48-producer strain, Food Microbiol., 30, 59, 10.1016/j.fm.2011.12.002
Cross, 1984, Release and purification of Trypanosoma brucei variant surface glycoprotein, J. Cell. Biochem., 24, 79, 10.1002/jcb.240240107
Cullen, 2017, A brief review of drug discovery research for Human African Trypanosomiasis, Curr. Med. Chem., 10.2174/0929867324666170120160034
David Barry, 2001, Antigenic variation in trypanosomes: enhanced phenotypic variation in a eukaryotic parasite, Adv. Parasitol., 49, 1, 10.1016/S0065-308X(01)49037-3
De Rycker, 2013, Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay, Antimicrob. Agents Chemother., 57, 2913, 10.1128/AAC.02398-12
Delgado, 2008, Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death, Cell Death Differ., 16, 406, 10.1038/cdd.2008.161
Dezfuli, 2006, Effects of experimental terbuthylazine exposure on the cells of Dicentrarchus labrax (L.), Chemosphere, 64, 1684, 10.1016/j.chemosphere.2006.01.023
Engstler, 2004, Kinetics of endocytosis and recycling of the GPI-anchored variant surface glycoprotein in Trypanosoma brucei, J. Cell Sci., 117, 1105, 10.1242/jcs.00938
Field, 2009, The trypanosome flagellar pocket, Nat. Rev. Microbiol., 7, 775, 10.1038/nrmicro2221
Gonzalez-Rey, 2006, VIP: an agent with license to kill infective parasites, Ann. N. Y. Acad. Sci., 1070, 303, 10.1196/annals.1317.032
Gonzalez-Rey, 2007, Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells, Arthritis Rheum., 56, 531, 10.1002/art.22394
Grande Burgos, 2014, The cyclic antibacterial peptide enterocin AS-48: isolation, mode of action, and possible food applications, Int. J. Mol. Sci., 15, 22706, 10.3390/ijms151222706
Greene, 2016, Trypanosome lytic Factor-1 initiates oxidation-stimulated osmotic lysis of Trypanosoma brucei brucei, J. Biol. Chem., 291, 3063, 10.1074/jbc.M115.680371
Haines, 2003, Cationic antimicrobial peptide killing of african Trypanosomes and Sodalis glossinidius, a bacterial symbiont of the insect vector of sleeping sickness, Vector Borne Zoonotic Dis., 3, 175, 10.1089/153036603322662165
Harrington, 2011, Antimicrobial peptide killing of african Trypanosomes, Parasite Immunol., 33, 461, 10.1111/j.1365-3024.2011.01294.x
Hu, 2006, Innate immune responses regulate trypanosome parasite infection of the tsetse fly Glossina morsitans morsitans, Mol. Microbiol., 60, 1194, 10.1111/j.1365-2958.2006.05180.x
Hu, 2005, An antimicrobial peptide with trypanocidal activity characterized from Glossina morsitans morsitans, Insect Biochem. Mol. Biol., 35, 105, 10.1016/j.ibmb.2004.10.007
Ishiyama, 2009, In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin, J. Antibiot. (Tokyo), 62, 303, 10.1038/ja.2009.32
Jenssen, 2006, Peptide antimicrobial agents, Clin. Microbiol. Rev., 19, 491, 10.1128/CMR.00056-05
Lanz, 1997, Use of FITC as a fluorescent probe for intracellular pH measurement, J. Fluoresc., 7, 317, 10.1023/A:1022586127784
Li, 2012, A role of autophagy in Trypanosoma brucei cell death, Cell Microbiol., 14, 1242, 10.1111/j.1462-5822.2012.01795.x
Luque-Ortega, 2012, Defeating Leishmania resistance to miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: a proof of mechanism for trypanosomatid chemotherapy, J. Control. Release Off. J. Control. Release Soc., 161, 835, 10.1016/j.jconrel.2012.05.023
Maqueda, 2004, Peptide AS-48: prototype of a new class of cyclic bacteriocins, Curr. Protein Pept. Sci., 5, 399, 10.2174/1389203043379567
Maqueda, 1993, Neutralizing antibodies against the peptide antibiotic AS-48: immunocytological studies, Antimicrob. Agents Chemother., 37, 148, 10.1128/AAC.37.1.148
McGwire, 2003, Killing of african Trypanosomes by antimicrobial peptides, J. Infect. Dis., 188, 146, 10.1086/375747
Mendoza, 1999, Antilisterial activity of peptide AS-48 and study of changes induced in the cell envelope properties of an AS-48-adapted strain of Listeria monocytogenes, Appl. Environ. Microbiol., 65, 618, 10.1128/AEM.65.2.618-625.1999
Montalban-Lopez, 2011, Are bacteriocins Underexploited? NOVEL applications for OLD antimicrobials, Curr. Pharm. Biotechnol, 12, 1205, 10.2174/138920111796117364
Morgan, 2001, Developmental and morphological regulation of clathrin-mediated endocytosis in Trypanosoma brucei, J. Cell Sci., 114, 2605, 10.1242/jcs.114.14.2605
Natesan, 2007, Activation of endocytosis as an adaptation to the mammalian host by Trypanosomes, Eukaryot. Cell, 6, 2029, 10.1128/EC.00213-07
Navarro, 1996, DNA rearrangements associated with multiple consecutive directed antigenic switches in Trypanosoma brucei, Mol. Cell Biol., 16, 3615, 10.1128/MCB.16.7.3615
Pal, 2002, Differential endocytic functions of Trypanosoma brucei Rab5 isoforms reveal a glycosylphosphatidylinositol-specific endosomal pathway, J. Biol. Chem., 277, 9529, 10.1074/jbc.M110055200
Pérez-Victoria, 2006, Combination of suboptimal doses of inhibitors Targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to miltefosine by inhibiting drug efflux, Antimicrob. Agents Chemother., 50, 3102, 10.1128/AAC.00423-06
Pham, 2017, Novel 1,2-dihydroquinazolin-2-ones: design, synthesis, and biological evaluation against Trypanosoma brucei, Bioorg. Med. Chem. Lett, 27, 3629, 10.1016/j.bmcl.2017.07.032
Proto, 2014, Tracking autophagy during proliferation and differentiation of Trypanosoma brucei, Microb. Cell Graz Austria, 1, 9, 10.15698/mic2014.01.120
Ramu, 2015, Bacteriocins and Their applications in food preservation, Crit. Rev. Food Sci. Nutr., 0
Räz, 1997, The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro, Acta Trop., 68, 139, 10.1016/S0001-706X(97)00079-X
Reinhardt, 2008
Riley, 2002, Bacteriocins: evolution, ecology, and application, Annu. Rev. Microbiol., 56, 117, 10.1146/annurev.micro.56.012302.161024
Rycker, 2012, A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes, PLoS Neglected Trop. Dis., 6, e1932, 10.1371/journal.pntd.0001932
Sánchez-Barrena, 2003, Structure of bacteriocin AS-48: from soluble state to membrane bound state, J. Mol. Biol., 334, 541, 10.1016/j.jmb.2003.09.060
Sánchez-Fernández, 2015, Antileishmanial activity of sp2-iminosugar derivatives, RSC Adv., 5, 21812, 10.1039/C5RA02627J
Sánchez-Hidalgo, 2011, AS-48 bacteriocin: close to perfection, Cell. Mol. Life Sci., 68, 2845, 10.1007/s00018-011-0724-4
Souto-Padrón, 1990, The surface charge of trypanosomatids of the genus Trypanosoma, Mem. Inst. Oswaldo Cruz, 85, 215, 10.1590/S0074-02761990000200013
Uzcátegui, 2007, Antiproliferative effect of dihydroxyacetone on Trypanosoma brucei bloodstream forms: cell cycle progression, subcellular alterations, and cell death, Antimicrob. Agents Chemother., 51, 3960, 10.1128/AAC.00423-07
Vanhollebeke, 2008, A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans, Science, 320, 677, 10.1126/science.1156296
Vreysen, 2013, Tsetse flies: Their biology and control using area-wide integrated pest management approaches, J. Invertebr. Pathol., 112, S15, 10.1016/j.jip.2012.07.026
Welburn, 2009, Controlling sleeping sickness – a review, Parasitology, 136, 1943, 10.1017/S0031182009006416
Wirtz, 1999, A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei, Mol. Biochem. Parasitol., 99, 89, 10.1016/S0166-6851(99)00002-X
Yeaman, 2001, Sec6/8 complexes on trans-Golgi network and plasma membrane regulate late stages of exocytosis in mammalian cells, J. Cell Biol., 155, 593, 10.1083/jcb.200107088